Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01450943 · ClinicalTrials.gov registry record · Phase 3
VA MERIT: A Comparative Efficacy Study: Treatment of Non-Healing Diabetic
A Phase 3 study of Diabetic Foot Ulcer, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT01450943: Completed Phase 3 study of Diabetic Foot Ulcer, sponsored by VA Office of Research and Development.
NCT01450943 is a Phase 3 study of Diabetic Foot Ulcer that has completed, run by VA Office of Research and Development. The registered enrollment target is 120 participants, below the 253-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01450943, a Phase 3 study of Diabetic Foot Ulcer, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to assess the effectiveness of cellular dermal replacement tissue vs. non-viable extracellular matrix (ECM) for the treatment of non-healing diabetic foot ulcers. Our hypothesis is that these devices are of equal efficacy.
Conditions Studied
Interventions
- DEVICE SECONDARY dressing gauze and tape
- PROCEDURE debridement, irrigation
- DEVICE Dermagraft
- DEVICE Oasis
Study Locations (1)
California
- VA Northern California Health Care System, Mather, CA - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2011-10-01 |
| Est. Completion | 2018-04-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01450943
The ClinicalTrials.gov registry entry for NCT01450943 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 253-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (53% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 4 interventions - of which SECONDARY dressing gauze and tape is the first listed.
NCT01450943 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01450943 about?
NCT01450943 is a clinical study titled "VA MERIT: A Comparative Efficacy Study: Treatment of Non-Healing Diabetic". The primary objective of this study is to assess the effectiveness of cellular dermal replacement tissue vs. non-viable extracellular matrix (ECM) for the treatment of non-healing diabetic foot ulcers. Our hypothesis is that these devices are of equal efficacy.
What is the current status of trial NCT01450943?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2011-10-01. Estimated completion is 2018-04-04.
What conditions does trial NCT01450943 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer.
What interventions are being tested in trial NCT01450943?
The interventions under investigation include: SECONDARY dressing gauze and tape (DEVICE), debridement, irrigation (PROCEDURE), Dermagraft (DEVICE), Oasis (DEVICE).
Who is sponsoring clinical trial NCT01450943?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01450943 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
RECRUITING · Phase 3
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
RECRUITING · Phase 4
-
Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.
RECRUITING
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.
RECRUITING · Phase 2
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.